dc.contributor.author |
Melagraki, G |
en |
dc.contributor.author |
Afantitis, A |
en |
dc.contributor.author |
Igglessi-Markopoulou, O |
en |
dc.contributor.author |
Detsi, A |
en |
dc.contributor.author |
Koufaki, M |
en |
dc.contributor.author |
Kontogiorgis, C |
en |
dc.contributor.author |
Hadjipavlou-Litina, DJ |
en |
dc.date.accessioned |
2014-03-01T01:32:01Z |
|
dc.date.available |
2014-03-01T01:32:01Z |
|
dc.date.issued |
2009 |
en |
dc.identifier.issn |
0223-5234 |
en |
dc.identifier.uri |
https://dspace.lib.ntua.gr/xmlui/handle/123456789/20022 |
|
dc.subject |
Anti-inflammatory |
en |
dc.subject |
Antioxidant |
en |
dc.subject |
Coumarins |
en |
dc.subject |
Lipoic acid |
en |
dc.subject.classification |
Chemistry, Medicinal |
en |
dc.subject.other |
antiinflammatory agent |
en |
dc.subject.other |
antioxidant |
en |
dc.subject.other |
lipoxygenase |
en |
dc.subject.other |
n(2 aminoethyl) 4 hydroxy 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n(2 aminoethyl) 4 hydroxy 6 methyl 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n(2 aminophenyl) 4 hydroxy 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n(2 aminophenyl) 4 hydroxy 6 methyl 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n(6 aminohexyl) 4 hydroxy 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n(8 aminooctyl) 4 hydroxy 6 methyl 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n(8 octylamino) 4 hydroxy 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n[2 [4 (1,2 dithiolan 3 yl)butanamido]ethyl] 4 hydroxy 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n[2 [4 (1,2 dithiolan 3 yl)butanamido]ethyl] 4 hydroxy 6 methyl 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n[6 [5 (1,2 dithiolan 3 yl)pentanamido]hexyl] 4 hydroxy 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n[8 [5 (1,2 dithiolan 3 yl)pentanamido]octyl] 4 hydroxy 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
n[8 [5 (1,2 dithiolan 3 yl)pentanamido]octyl] 4 hydroxy 6 methyl 2 oxo 2h chromene 3 carboxamide |
en |
dc.subject.other |
thioctic acid |
en |
dc.subject.other |
unclassified drug |
en |
dc.subject.other |
animal experiment |
en |
dc.subject.other |
animal model |
en |
dc.subject.other |
antiinflammatory activity |
en |
dc.subject.other |
antioxidant activity |
en |
dc.subject.other |
article |
en |
dc.subject.other |
controlled study |
en |
dc.subject.other |
drug design |
en |
dc.subject.other |
drug screening |
en |
dc.subject.other |
drug synthesis |
en |
dc.subject.other |
edema |
en |
dc.subject.other |
enzyme inhibition |
en |
dc.subject.other |
female |
en |
dc.subject.other |
mouse |
en |
dc.subject.other |
nonhuman |
en |
dc.subject.other |
paw edema |
en |
dc.subject.other |
rat |
en |
dc.subject.other |
structure activity relation |
en |
dc.subject.other |
Animals |
en |
dc.subject.other |
Anti-Inflammatory Agents |
en |
dc.subject.other |
Antioxidants |
en |
dc.subject.other |
Coumarins |
en |
dc.subject.other |
Edema |
en |
dc.subject.other |
Female |
en |
dc.subject.other |
Lipoxygenase |
en |
dc.subject.other |
Lipoxygenase Inhibitors |
en |
dc.subject.other |
Male |
en |
dc.subject.other |
Rats |
en |
dc.subject.other |
Soybeans |
en |
dc.subject.other |
Thioctic Acid |
en |
dc.title |
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1016/j.ejmech.2008.12.027 |
en |
heal.identifier.secondary |
http://dx.doi.org/10.1016/j.ejmech.2008.12.027 |
en |
heal.language |
English |
en |
heal.publicationDate |
2009 |
en |
heal.abstract |
In the present work a series of novel coumarin-3-carboxamides and their hybrids with the alpha-lipoic acid were designed, synthesized and tested as potent antioxidant and anti-inflammatory agents. The new compounds were evaluated for their antioxidant activity, their activity to inhibit in vitro lipoxygenase and their in vivo anti-inflammatory activity. In general, the derivatives were generally found to present antioxidant and anti-inflammatory activities. Discussion is made based on the results for the structure-activity relationships in order to define the structural features required for activity. (C) 2009 Elsevier Masson SAS. All rights reserved. |
en |
heal.publisher |
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER |
en |
heal.journalName |
European Journal of Medicinal Chemistry |
en |
dc.identifier.doi |
10.1016/j.ejmech.2008.12.027 |
en |
dc.identifier.isi |
ISI:000266524900032 |
en |
dc.identifier.volume |
44 |
en |
dc.identifier.issue |
7 |
en |
dc.identifier.spage |
3020 |
en |
dc.identifier.epage |
3026 |
en |